M. Tamm (Basel, Switzerland), H. Ghedira (Ariana, Tunisia)
Systemic inflammation, quality of life and comorbidity in chronic obstructive pulmonary disease
J. Sauleda, B. Núñez, A. Noguera, E. Monsó, J. Gea, J. García, J. M. Ántó, C. Villena, F. Gómez, J. Roca, E. Farrero, A. Agustí (Palma de Mallorca, Bunyola, Badalona, Barcelona, Hospitalet de Llobreg
|  |
The relationship of serum erythropoietin levels and polycythemia in hypoxemic COPD patients
F. Orhan, D. Ediger, E. Uzaslan, M. Karadag, E. Ege, O. Gözü (Bursa, Turkey)
| |
Plasma biomarkers and response to therapy at exacerbation of COPD
J. R. Hurst, W. R. Perera, G. C. Donaldson, G. W. Hagan, J. A. Wedzicha (London, United Kingdom)
| |
Pro-adrenomedullin and pro-endothelin-1 for assessment and prognosis of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
D. Stolz, M. Christ-Crain, N. Morgenthaler, D. Miedinger, J. Leuppi, R. Bingisser, C. Müller, J. Struck, B. Müller, M. Tamm (Basel, Switzerland; Hennigsdorf, Germany)
| |
Importance of PRO-BNP and troponin-I values in finding relation between cardiac origin of COPD attacks
S. N. Sokucu, E. C. Seyhan, S. Altin, E. Cetinkaya, N. Simsek, A. Gencoglu (Istanbul, Turkey)
|  ![]()  ![]()  |
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
E. Sala, C. Villena, C. Fernandez-Palomeque, A. Rios, H. Martinez, B. Garcia-Cosio, J. Vidal, J. Garcia, B. Nunez, A. Agusti (Mallorca, Spain)
| ![]() ![]() |
Leptin changes with exercise in COPD
A. Ionescu, L. Nixon, C. Bolton, T. Mickleboroough, R. Pettit, W. Evans, D. Shale (Cardiff, United Kingdom; Bloomington, United States Of America)
| ![]() ![]() |
Systemic inflammation in exacerbated patients with chronic obstructive pulmonary disease (COPD): the role of alterations in leptin/ghrelin ratio and/or leptin/adiponectin ratio
G. Krommidas, G. Papatheodorou, D. Markoulaki, N. Koulouris, N. Chatzianastasiou, C. Roussos, S. Loukides (Athens, Greece)
| ![]() ![]() |